ODYSSEY trial wins 2021 Hector Award

29 Oct, 2021

It was announced at the 8th European AIDS Conference that Angela Colbers and David Burger received the Hector Research Award in HIV 2021 in clinical and/or epidemiological science on behalf of the ODYSSEY trial team!

The winning paper Simplified dolutegravir dosing for children with HIV weighting 20kg or more pharmacokinetic and safety substudies of the multicentre randomised ODYSSEY trial, can be found here.

Congratulations to the entire study team and thank you to all the families and children who participated in the ODYSSEY trial.

Sponsored by Penta and funded by ViiV Healthcare, the ODYSSEY trial’s main objective was to evaluate the efficacy and safety of a once daily dose of dolutegravir-based antiretroviral therapy compared with the current standard HIV treatment in children and adolescents with HIV.